Authors:
VUNNAM S
JUVVADI P
ROTONDI KS
MERRIFIELD RB
Citation: S. Vunnam et al., SYNTHESIS AND STUDY OF NORMAL, ENANTIO, RETRO, AND RETROENANTIO ISOMERS OF CECROPIN A-MELITTIN HYBRIDS, THEIR END GROUP EFFECTS AND SELECTIVE ENZYME INACTIVATION, The journal of peptide research, 51(1), 1998, pp. 38-44
Citation: Cg. Unson et al., POSITIVELY CHARGED RESIDUES AT POSITION-12, POSITION-17, AND POSITION-18 OF GLUCAGON ENSURE MAXIMUM BIOLOGICAL POTENCY, The Journal of biological chemistry, 273(17), 1998, pp. 10308-10312
Citation: S. Vunnam et al., SYNTHESIS AND ANTIBACTERIAL ACTION OF CECROPIN AND PROLINE-ARGININE-RICH PEPTIDES FROM PIG INTESTINE, The journal of peptide research, 49(1), 1997, pp. 59-66
Authors:
DURVASULA RV
GUMBS A
PANACKAL A
KRUGLOV O
AKSOY S
MERRIFIELD RB
RICHARDS FF
BEARD CB
Citation: Rv. Durvasula et al., PREVENTION OF INSECT-BORNE DISEASE - AN APPROACH USING TRANSGENIC SYMBIOTIC BACTERIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(7), 1997, pp. 3274-3278
Citation: Cg. Unson et al., ANTIBODIES AGAINST SPECIFIC EXTRACELLULAR EPITOPES OF THE GLUCAGON RECEPTOR BLOCK GLUCAGON BINDING, Proceedings of the National Academy of Sciences of the United Statesof America, 93(1), 1996, pp. 310-315
Citation: P. Juvvadi et al., SYNTHETIC MELITTIN, ITS ENANTIO, RETRO, AND RETROENANTIO ISOMERS, ANDSELECTED CHIMERIC ANALOGS - THEIR ANTIBACTERIAL, HEMOLYTIC, AND LIPIDBILAYER ACTION, Journal of the American Chemical Society, 118(38), 1996, pp. 8989-8997
Authors:
MERRIFIELD EL
MITCHELL SA
UBACH J
BOMAN HG
ANDREU D
MERRIFIELD RB
Citation: El. Merrifield et al., D-ENANTIOMERS OF 15-RESIDUE CECROPIN A-MELITTIN HYBRIDS, International journal of peptide & protein research, 46(3-4), 1995, pp. 214-220
Authors:
MERRIFIELD RB
JUVVADI P
ANDREU D
UBACH J
BOMAN A
BOMAN HG
Citation: Rb. Merrifield et al., RETRO AND RETROENANTIO ANALOGS OF CECROPIN MELITTIN HYBRIDS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3449-3453
Authors:
UNSON CG
CYPESS AM
KIM HN
GOLDSMITH PK
CARRUTHERS CJL
MERRIFIELD RB
SAKMAR TP
Citation: Cg. Unson et al., CHARACTERIZATION OF DELETION AND TRUNCATION MUTANTS OF THE RAT GLUCAGON RECEPTOR - 7 TRANSMEMBRANE SEGMENTS ARE NECESSARY FOR RECEPTOR TRANSPORT TO THE PLASMA-MEMBRANE AND GLUCAGON BINDING, The Journal of biological chemistry, 270(46), 1995, pp. 27720-27727
Citation: Cg. Unson et Rb. Merrifield, IDENTIFICATION OF AN ESSENTIAL SERINE RESIDUE IN GLUCAGON - IMPLICATION FOR AN ACTIVE-SITE TRIAD, Proceedings of the National Academy of Sciences of the United Statesof America, 91(2), 1994, pp. 454-458
Citation: Cg. Unson et al., MULTIPLE-SITE REPLACEMENT ANALOGS OF GLUCAGON - A MOLECULAR-BASIS FORANTAGONIST DESIGN, The Journal of biological chemistry, 269(17), 1994, pp. 12548-12551
Citation: Cg. Unson et al., ROLES OF ASPARTIC-ACID-15 AND ASPARTIC-ACID-21 IN GLUCAGON ACTION - RECEPTOR ANCHOR AND SURROGATES FOR ASPARTIC-ACID-9, Biochemistry, 33(22), 1994, pp. 6884-6887
Authors:
KAISER E
PICART F
KUBIAK T
TAM JP
MERRIFIELD RB
Citation: E. Kaiser et al., SELECTIVE DEPROTECTION OF THE N-ALPHA-TERT-BUTYLOXYCARBONYL GROUP IN SOLID-PHASE PEPTIDE-SYNTHESIS WITH CHLOROTRIMETHYLSILANE AND PHENOL, Journal of organic chemistry, 58(19), 1993, pp. 5167-5175